Apyx Medical (APYX) EBT Margin (2011 - 2026)
Apyx Medical's (APYX) quarterly EBT Margin came in at 21.23% in Q2 2026, up 1120.0% on a YoY basis from 1.74% in Q2 2025, and down 32.6% quarter-over-quarter from 16.01% in Q1 2026.
Powered by 
Analysis
Apyx Medical (APYX) EBT Margin (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has reported EBT Margin for 16 consecutive years, with 21.23% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 1120.0% year-over-year to 21.23%; the trailing twelve-month figure through Jun 2026 stood at 18.82% (up 2311.0% YoY), and the FY2025 full-year result was 26.22%, up 2734.0% from the prior year.
- EBT Margin declined to 21.23% in Q2 2026 per APYX's latest filing, from 16.01% in the prior quarter.
- Across five years, EBT Margin topped out at 7.02% in Q2 2023 and bottomed at 73.57% in Q1 2024.
- Historically, EBT Margin has averaged 40.99% across 5 years, with a median of 45.31% in 2022.
- The sharpest annual moves came in 2023 and 2024: EBT Margin surged 4500 bps in 2023, then sank 4678 bps in 2024.
- Over 5 years, EBT Margin stood at 46.9% in 2022, then sank by 39 bps to 65.05% in 2023, then rose by 24 bps to 49.4% in 2024, then surged by 56 bps to 21.74% in 2025, then grew by 2 bps to 21.23% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 21.23%, 16.01%, and 21.74% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.32% |
| 10 | Apyx Medical | 125.85 Mn | 98.23 Mn | 8.87 Mn | -21.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -21.23% |
| Mar 31, 2026 | -16.01% |
| Dec 31, 2025 | -21.74% |
| Sep 30, 2025 | -14.58% |
| Jun 30, 2025 | -32.44% |
| Mar 31, 2025 | -43.72% |
| Dec 31, 2024 | -49.40% |
| Sep 30, 2024 | -40.60% |
| Jun 30, 2024 | -53.80% |
| Mar 31, 2024 | -73.57% |
| Dec 31, 2023 | -65.05% |
| Sep 30, 2023 | -41.69% |
| Jun 30, 2023 | -7.02% |
| Mar 31, 2023 | -47.76% |
| Dec 31, 2022 | -46.90% |
| Sep 30, 2022 | -63.03% |
| Jun 30, 2022 | -52.02% |
| Mar 31, 2022 | -47.21% |
| Dec 31, 2021 | -11.15% |
| Sep 30, 2021 | -35.17% |